We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $786B
1-Year Est. Return 40.34%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+21.85%
1 Year Est. Return
+40.34%
3 Year Est. Return
+112.81%
5 Year Est. Return
+128.34%
10 Year Est. Return
+415.77%
AUM
$786B
AUM Growth
+$120B
Cap. Flow
-$10.6B
Cap. Flow %
-1.35%
Top 10 Hldgs %
13.38%
Holding
11,684
New
1,279
Increased
4,220
Reduced
4,368
Closed
1,272

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.15B
2
HONA
Honeywell Aerospace
HONA
+$611M
3
SPCX
SpaceX
SPCX
+$567M
4
AAPL icon
Apple
AAPL
+$511M
5
JBL icon
Jabil
JBL
+$463M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$1.49B
2
WDC icon
Western Digital
WDC
+$1.42B
3
LITE icon
Lumentum
LITE
+$951M
4
INTC icon
Intel
INTC
+$785M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$749M

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.93%
2 Technology 18.61%
3 Financials 7.85%
4 Industrials 6.94%
5 Healthcare 5.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DSGN icon
6176
Design Therapeutics
DSGN
$802M
$503K ﹤0.01%
34,761
+17,670
+103% +$220K
HVT icon
6177
Haverty Furniture Companies
HVT
$425M
$503K ﹤0.01%
19,696
-17,596
-47% -$399K
VUZI icon
6178
Vuzix
VUZI
$232M
$503K ﹤0.01%
173,283
-139,020
-45% -$438K
RDWR icon
6179
Radware
RDWR
$1.29B
$502K ﹤0.01%
16,272
+3,359
+26% +$92.9K
PSCE icon
6180
Invesco S&P SmallCap Energy ETF
PSCE
$109M
$501K ﹤0.01%
9,110
-16,973
-65% -$1.02M
CSHR
6181
CoinShares PLC
CSHR
$680M
$499K ﹤0.01%
+132,297
New +$697K
FSSL
6182
FS Specialty Lending Fund
FSSL
$906M
$498K ﹤0.01%
44,674
+18,137
+68% +$214K
JBI icon
6183
Janus International
JBI
$604M
$497K ﹤0.01%
89,469
-306,795
-77% -$1.61M
ACB
6184
Aurora Cannabis
ACB
$244M
$495K ﹤0.01%
177,561
+25,293
+17% +$84.6K
VEL icon
6185
Velocity Financial
VEL
$634M
$493K ﹤0.01%
26,707
+9,275
+53% +$169K
CTRI icon
6186
CALL
Centuri Holdings
CTRI
$1.93B
$493K ﹤0.01%
16,300
DJD icon
6187
Invesco Dow Jones Industrial Average Dividend ETF
DJD
$503M
$492K ﹤0.01%
7,770
-1,397
-15% -$85.9K
PMM
6188
Franklin Managed Municipal Income Trust
PMM
$251M
$492K ﹤0.01%
75,277
-2,919
-4% -$18.2K
ADUR
6189
Aduro Clean Technologies
ADUR
$451M
$492K ﹤0.01%
31,212
-44,005
-59% -$597K
AURA icon
6190
Aura Biosciences
AURA
$683M
$492K ﹤0.01%
69,230
-49,674
-42% -$355K
VREX icon
6191
Varex Imaging
VREX
$781M
$491K ﹤0.01%
47,098
-6,973
-13% -$75.2K
BDTX icon
6192
Black Diamond Therapeutics
BDTX
$111M
$491K ﹤0.01%
265,313
-299,525
-53% -$733K
LNSR icon
6193
LENSAR
LNSR
$87.1M
$489K ﹤0.01%
85,634
+2,362
+3% +$13.5K
ADV icon
6194
Advantage Solutions
ADV
$423M
$489K ﹤0.01%
11,302
-9,163
-45% -$324K
GOVI icon
6195
Invesco Equal Weight 0-30 Year Treasury ETF
GOVI
$1.21B
$489K ﹤0.01%
17,993
-1,548
-8% -$42K
GOOS
6196
Canada Goose Holdings
GOOS
$729M
$488K ﹤0.01%
51,365
-42,218
-45% -$445K
BWFG icon
6197
Bankwell Financial Group
BWFG
$533M
$487K ﹤0.01%
8,290
-2,522
-23% -$134K
FETH
6198
Fidelity Ethereum Fund
FETH
$1.32B
$483K ﹤0.01%
+30,700
New +$629K
GDE icon
6199
WisdomTree Efficient Gold Plus Equity Strategy Fund
GDE
$474M
$482K ﹤0.01%
7,889
-108
-1% -$7.17K
IVVD icon
6200
Invivyd
IVVD
$220M
$482K ﹤0.01%
552,260
-62,430
-10% -$78.3K

Similar funds

UBS Group's Q2 2026 Portfolio in Review

As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2026 filing shows 1,279 new, 4,220 increased, 4,368 reduced and 1,272 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.

By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.

  • UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
  • UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
  • UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
  • UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
  • UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
  • UBS Group opened 1,279 new positions and closed 1,272 in Q2 2026.
  • UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.